Jeff Marek gives a tempature check on how eager staff members around the NHL are for the Maple Leafs General Manager job. The Gulf states who want Trump 'to finish the job' in Iran April arrives with ...

A first-of-its-kind weight loss pill will become the latest drug to be offered on President Trump's cost comparison platform "Trump Rx," CBS News exclusively learned. Foundayo, a GLP-1 drug, is a ...

Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year. Lilly’s once-daily pill, called Foundayo, was approved ...

Eli Lilly’s orforglipron (Foundayo) has secured FDA approval for weight loss. The drug is the first small-molecule GLP-1 receptor agonist to secure approval, offering a potential convenience edge over ...

Orforglipron gives patients oral option for obesity treatment from May Dubai: The Emirates Drug Establishment (EDE) has approved Foundayo™ (orforglipron), an innovative oral treatment for chronic ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. When The Matrix was absorbed into MAGA’s political symbolism during ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections. By Dani Blum and Rebecca Robbins The Food and Drug Administration on Wednesday approved a ...

A federal judge allowed the abortion pill mifepristone to continue being distributed by mail nationwide for now, but warned the Biden-era policy could soon face major legal changes as a Food and Drug ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s obesity pill ...

The Food and Drug Administration on April 1 approved Eli Lilly's new weight-loss pill, giving consumers a second option in the growing non-injectable GLP-1 weight-loss drug market. Lilly said it will ...

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily, the pill is made by pharmaceutical company Eli Lilly, which also manufactures the ...